BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16476821)

  • 1. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging.
    Lewis AM; Yu M; DeArmond SJ; Dillon WP; Miller BL; Geschwind MD
    Arch Neurol; 2006 Feb; 63(2):288-90. PubMed ID: 16476821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy: case report.
    Caboclo LO; Huang N; Lepski GA; Livramento JA; Buchpiguel CA; Porto CS; Nitrini R
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):458-61. PubMed ID: 12131950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.
    Ritchie DL; Adlard P; Peden AH; Lowrie S; Le Grice M; Burns K; Jackson RJ; Yull H; Keogh MJ; Wei W; Chinnery PF; Head MW; Ironside JW
    Acta Neuropathol; 2017 Aug; 134(2):221-240. PubMed ID: 28349199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients.
    Douet JY; Huor A; Cassard H; Lugan S; Aron N; Mesic C; Vilette D; Barrio T; Streichenberger N; Perret-Liaudet A; Delisle MB; Péran P; Deslys JP; Comoy E; Vilotte JL; Goudarzi K; Béringue V; Barria MA; Ritchie DL; Ironside JW; Andréoletti O
    Acta Neuropathol Commun; 2021 Aug; 9(1):145. PubMed ID: 34454616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone.
    Croes EA; Roks G; Jansen GH; Nijssen PC; van Duijn CM
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):792-3. PubMed ID: 12023427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebral magnetic resonance imaging in iatrogenic Creutzfeldt-Jacob disease].
    Gurau C; Zeghoudi AC; Atlaoui-Rabia S; Charitanski D; Mallecourt J
    Presse Med; 2005 Sep; 34(15):1080-1. PubMed ID: 16334885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cognitive decline in Creutzfeldt-Jakob disease associated with human growth hormone treatment.
    Cordery RJ; Hall M; Cipolotti L; Al-Sarraj S; O'Donovan DG; Davidson L; Adlard P; Rossor MN
    J Neurol Neurosurg Psychiatry; 2003 Oct; 74(10):1412-6. PubMed ID: 14570836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologic verification of Creutzfeldt-Jakob disease in the exhumed American recipient of human pituitary growth hormone: epidemiologic and pathogenetic implications.
    Tintner R; Brown P; Hedley-Whyte ET; Rappaport EB; Piccardo CP; Gajdusek DC
    Neurology; 1986 Jul; 36(7):932-6. PubMed ID: 3520381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease.
    Oppenheim C; Zuber M; Galanaud D; Detilleux M; Bolgert F; Mas JL; Chiras J; Meder JF
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1066-9. PubMed ID: 15201378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches.
    Ritchie DL; Barria MA; Peden AH; Yull HM; Kirkpatrick J; Adlard P; Ironside JW; Head MW
    Acta Neuropathol; 2017 Apr; 133(4):579-595. PubMed ID: 27812793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone.
    Purro SA; Farrow MA; Linehan J; Nazari T; Thomas DX; Chen Z; Mengel D; Saito T; Saido T; Rudge P; Brandner S; Walsh DM; Collinge J
    Nature; 2018 Dec; 564(7736):415-419. PubMed ID: 30546139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.
    Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I
    Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iatrogenic Creutzfeldt-Jakob disease 22 years after human growth hormone therapy: clinical and radiological features.
    Furtner M; Gelpi E; Kiechl S; Knoflach M; Zangerl A; Gotwald T; Willeit J; Maier H; Ströbel T; Unterberger U; Budka H
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):229-31. PubMed ID: 18202218
    [No Abstract]   [Full Text] [Related]  

  • 15. Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone.
    Mikol J; Deslys JP; Zou WQ; Xiao W; Brown P; Budka H; Goutieres F
    Clin Neuropathol; 2012; 31(3):127-34. PubMed ID: 22551916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone.
    Appleby BS; Lu M; Bizzi A; Phillips MD; Berri SM; Harbison MD; Schonberger LB
    Emerg Infect Dis; 2013 Apr; 19(4):682-4. PubMed ID: 23750511
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of high b-value diffusion-weighted MRI in the diagnosis of Creutzfeldt-Jakob disease.
    Riva-Amarante E; Jiménez-Huete A; Toledano R; Calero M; Alvarez-Linera J; Escribano J; Sánchez Migallón MJ; Franch O
    Neurologia; 2011; 26(6):331-6. PubMed ID: 21345540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology.
    Duyckaerts C; Sazdovitch V; Ando K; Seilhean D; Privat N; Yilmaz Z; Peckeu L; Amar E; Comoy E; Maceski A; Lehmann S; Brion JP; Brandel JP; Haïk S
    Acta Neuropathol; 2018 Feb; 135(2):201-212. PubMed ID: 29209767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI sequence findings in sporadic Creutzfeldt-Jakob disease.
    Tian HJ; Zhang JT; Lang SY; Wang XQ
    J Clin Neurosci; 2010 Nov; 17(11):1378-80. PubMed ID: 20727770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.